| GENERIC NAME | Peptide ImmunoModulator |
| CLINICAL STUDY | in EU; IL & South Africa |
| INDICATION'S | Diabetes Type-1 |
| STATUS | Phase III |
| UPDATE | 06.14.07 |
| COMPANY | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |